USANA Health Sciences (NYSE: USNA) and Nautilus Group, Inc. (The) (NYSE:NLS) are both small-cap non-cyclical consumer goods & services companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability and institutional ownership.

Insider and Institutional Ownership

45.0% of USANA Health Sciences shares are owned by institutional investors. Comparatively, 99.1% of Nautilus Group, Inc. (The) shares are owned by institutional investors. 53.2% of USANA Health Sciences shares are owned by company insiders. Comparatively, 3.7% of Nautilus Group, Inc. (The) shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Volatility & Risk

USANA Health Sciences has a beta of 1.07, suggesting that its stock price is 7% more volatile than the S&P 500. Comparatively, Nautilus Group, Inc. (The) has a beta of 2.12, suggesting that its stock price is 112% more volatile than the S&P 500.

Valuation & Earnings

This table compares USANA Health Sciences and Nautilus Group, Inc. (The)’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio NetIncome Earnings Per Share Price/Earnings Ratio
USANA Health Sciences $1.01 billion 1.60 $100.04 million $3.63 18.51
Nautilus Group, Inc. (The) $406.04 million 1.00 $34.17 million $0.95 13.95

USANA Health Sciences has higher revenue and earnings than Nautilus Group, Inc. (The). Nautilus Group, Inc. (The) is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares USANA Health Sciences and Nautilus Group, Inc. (The)’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
USANA Health Sciences 8.79% 26.38% 19.20%
Nautilus Group, Inc. (The) 7.28% 18.54% 9.76%

Analyst Ratings

This is a summary of recent ratings and recommmendations for USANA Health Sciences and Nautilus Group, Inc. (The), as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
USANA Health Sciences 0 0 1 0 3.00
Nautilus Group, Inc. (The) 0 3 4 0 2.57

USANA Health Sciences presently has a consensus target price of $80.00, suggesting a potential upside of 19.05%. Nautilus Group, Inc. (The) has a consensus target price of $18.96, suggesting a potential upside of 43.13%. Given Nautilus Group, Inc. (The)’s higher probable upside, analysts clearly believe Nautilus Group, Inc. (The) is more favorable than USANA Health Sciences.

Summary

USANA Health Sciences beats Nautilus Group, Inc. (The) on 10 of the 14 factors compared between the two stocks.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc. develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia. Its product lines include USANA Nutritionals Essentials, Optimizers, Foods, Sense-beautiful science and All Other. Its USANA Nutritionals Essentials product line includes vitamin and mineral supplements that provide a foundation of total body nutrition for every age group beginning with children of approximately one year. Its Optimizers product line consists of targeted supplements designed to meet individual health and nutritional needs. Its Sense-beautiful science product line includes science-based, personal care products that support skin and hair by providing topical nourishment, moisturization and protection.

Nautilus Group, Inc. (The) Company Profile

Nautilus, Inc. is a consumer fitness products company. The Company operates through two segments: Direct and Retail. Its principal business activities include designing, developing, sourcing and marketing of cardio and strength fitness products and related accessories for consumer use, primarily in the United States and Canada, but also in international markets outside North America. The Direct business offers products directly to consumers through television advertising, catalogs and the Internet. In its Direct business, the Company markets and sells its products, principally Bowflex cardio and strength products, directly to consumers. The Retail business offers its products through a network of independent retail companies and specialty retailers with stores and Websites located in the United States and internationally. In its Retail business, the Company markets and sells a line of consumer fitness equipment under the Nautilus, Octane Fitness, Schwinn, Universal and Bowflex brands.

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.